in turn, undergoes further reactions to form toxic derivatives such as hydrogen peroxide, hydroxyl radical (OH'-), organic 0, radicals and hypochlorite ion, which are then used by the cell to destroy ingested micro-organisms (Babior & Crowley, 1973; Badwey & Karnovsky, 1980; Tauber et al. 1983 ). The massive increases in 0, consumption and O2 radical production are referred to as the respiratory burst.
At the heart of the respiratory burst is a flavoprotein enzyme, NADPH oxidase, which catalyses the one electron reduction of 0, to superoxide according to the following reaction :
NADPH + 2 0 , + NADP+ + H+ + 20;-.
Because of the high rates of superoxide production by the stimulated PMN, it is necessary for the cell to regenerate NADPH. This is accomplished by the first two reactions of the hexose monophosphate shunt, glucose-6-phosphate dehydrogenase (EC I . I . I .49 ; G6PD) and 6-phospholgluconate dehydrogenase (EC I . I . I 4 3 ) which reduce NADP+ back to NADPH. Measurements of hexose monophosphate shunt activity in PMN have revealed twenty-fold increases in metabolic activity following phagocytic stimulation (Curnutte & Boxer, 1985) . As previously indicated, the immediate product of the NADPH oxidase reaction is superoxide ion. Although superoxide itself is only weakly bactericidal, this reactive 0, radical is capable of undergoing further reactions to generate other toxic 0, derivatives such as H,O,. Superoxide generated either on the surface of the cell, or within the confines of the phagolysome, can leak into the cytoplasm and cause cellular damage as on the surface of the plasma membrane. The cytoplasm of the leucocyte contains an enzyme, superoxide dismutase (EC I . I S . I . I ; SOD) that rapidly destroys superoxide according to the following reaction: available at https://www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19860071 0;-+ 0;-+ 2H+ -+ H20,+ 0,-.
The H,O, generated by this reaction is detoxified in the leucocyte cytoplasm by the glutathione cycle. The NADPH consumed by the glutathione cycle is also regenerated by the reactions of the hexose monophosphate shunt.
The central role of NADPH oxidase in the respiratory burst is highlighted by studies with PMN from patients with chronic granulomatous disease (Gallin et al. 1983; Tauber et al. 1983) . PMN from patients with both X-linked and autosomal recessive chronic granulomatous disease show no measurable respiratory burst. PMN from patients with chronic granulomatous disease undergo normal to rapid rates of chemotaxis, ingestion and degranulation. These normal functions coupled with the defective respiratory burst explain why chronic granulomatous disease patients are plagued with organisms which are catalase (EC 1.11.1.6)-positive but not those which are catalase-negative. Catalase-negative microbes are unable to destroy their endogenously produced H,O, so that when they are ingested by chronic granulomatous disease cells they release small but significant quantities of H,O, within the confines of the phagolysome. This microbially derived H,O, is then used by the myeloperoxidase system to generate toxic 0, derivatives which are then capable of killing the microsrganism. Since catalase-positive organisms destroy all their H,O,, there is no supplemental source available to the chronic granulomatous disease leucocyte.
The importance of oxidizing-radicals to the microbial system of the PMN is shown by experiments in which they are intercepted before they can interact with their targets. Microbicidal activity is inhibited by catalase, by SOD, or by 0,-radical scavengers such as mannitol. Since the 0, radicals produced by the PMN are capable of damaging not only bacteria but also normal tissues in sites of inflammation, these radical scavengers along with a-tocopherol are being studied as anti-inflammatory agents.
There is growing evidence that PMN are activated in vivo by complement or immune complexes in disorders such as adult respiratory distress syndrome (ARDS) and thermal injury (Rinaldo & Rogers, 1982; Wolach et uZ. 1984) . In animal models of ARDS, lung damage can be minimized when 0,-radical scavengers are administered during the course of the disease (Till et al. 1985; Tvedten et al. 1985) . It would appear then that anti-oxidants can be employed to manipulate chemotaxis and phagocytosis of PMN through their ability to scavenge released oxidant products as well as attenuate tissue injury affected by their products.
Consequence of a-tocopherol deficiency on PMNfunction
In neonates, both random motility of PMN and chemotaxis are diminished (Miller, 1971) . Other abnormalities of PMN phagocytes have been noted in human newborn infants. These include the decreased intracellular killing in the presence of a stress or a secondary illness. The aetiology of these abnormalities of phagocyte function remain unknown but possibly could relate to differences in membrane VOl. 45
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properties between newborn and adult PMN (Wright et al. 1975 Thus, we rendered weanling rats a-tocopherol deficient and evaluated PMN behaviour. Following 8 weeks of an a-tocopherol-deficient diet, serum a-tocopherol levels were 0 . 6 (SD 0 . I) mg/l compared with levels in control rats of I 1 . 7 (SD 0.6) mg/l. PMN obtained from the peritoneal cavity of rats revealed that directed cell movement but not random motility was depressed in the a-tocopheroldeficient animals. Similarly, the ingestion of both C3b opsonized or IgG opsonized paraffin-oil droplets was significantly compromised in PMN obtained from the a-tocopheroldepleted animals ( Table I) . We further found an increase of 1.5-fold in the amount of peroxidized lipid membrane as assayed by the formation of malonyl dialdehyde in the a-tocopherol-depleted compared with control PMN.
Further studies revealed that a-tocopheroldeficient PMN were metabolically more active than controls as evidenced by an increase in 0, consumption and release of H,O, into the extracellular medium. We developed the hypothesis that the membrane-associated NADPH oxidase responsible for the consumption of 0, and generation of 0, by-products in the a-tocopheroldeficient PMN was situated in an abnormal lipid milieu which in turn facilitated greater activation of the enzyme and generation of auto-toxic concentrations of H,02.
To appreciate the consequence of a-tocopherol depletion, it is necessary to outline the role of the vitamin in inhibiting the oxidation of unsaturated fatty acids. The oxidation of fatty acids is dependent on the presence of double bonds which are present in the unsaturated fatty acids but not in the saturated fats Table I (Mead, 1976) . Such auto-oxidation of an unsaturated fatty acid, like linoleic acid, has been postulated to occur as follows: ( I ) loss of a hydrogen ion atom from the carbon in the a position of the double bond; ( 2 ) non-enzymic oxidation of the C atom to a free peroxidic radical; (3) reaction of the unsaturable lipid-free radicals with other unsaturated fatty acid molecules which generate lipid hydroperoxides, and more lipid-free radicals.
Because of its capacity to scavenge lipid-free radicals through the phenolic group found on the chroman ring of the molecule (Fig. I) , a-tocopherol prevents the oxidation reactions described previously. In turn the fatty acid and side chain of the a-tocopherol molecule account for its solubility in lipids thereby rendering the vitamin useful in preventing oxidation within the plasma membrane.
ESfects of antioxidants including a-tocopherol on normal PMN function Clearly, a-tocopherol deficiency leads to sufficient damage which compromises PMN function. On the other hand, what are the consequences of supplementing the diet with a-tocopherol on PMN function? To answer this question, we administered I '07 (1600 units) a-tocopherol/d to adult volunteers for z weeks (Baehner et al. 1977) . Serum a-tocopherol levels rose from a range of 11.2 (SD 1.6) to 18.2 (SD 0.4) mg/l. As noted in Table 2 , rate of uptake of Cppsonized lipopolysaccharide-coated paraffin-oil droplets increased from 0.060 (SD 0.01 5) mg/107 PMN per min before a-tocopherol supplementation to values of 0.76 (SD 0.009) mg/107 PMN per min during a-tocopherol ingestion. On the other hand, despite the greater ability to phagocytose, u-tocopherol-replete PMN showed a mildly reduced ability to kJl bacteria compared with control at IOO min. The extent of this acquired abnormality was far less than that observed for PMN in patients with chronic granulomatous disease. These results suggest that the decreased release of H,02 by a-tocopherol-replete PMN may result in less oxidative damage to their membranes so that they are more efficient in ingestion of C 3-opsonized lipopolysaccharide-coated paraffin-oil droplets but that the failure to produce this reactive species also serves to protect ingested micro-organisms from the peroxide-mediated attack which results in their demise.
We found that a-tocopherol-replete PMN released superoxide normally to the extracellular medium but released only 45% of the amount of H202 as control available at https://www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19860071 [ ~-~~Clglucose oxidation increased by 4.4-fold during phagocytosis of latex particles over 15 min but only increased by z.9-fold in the a-tocopherol-replete PMN. Although H,O, released both extracellularly and intracellularly were reduced in the a-tocopherol-replete PMN, the cells were able to utilize 0, normally. The site of H,O, produced by NADPH oxidase was determined in PMN obtained from the blood of volunteers receiving I '07 g ( I 600 units) a-tocopheroUd (Table 3) . For these studies, PMN were incubated in the presence of NADPH and cerium chloride and allowed to generate H,O, by phagocytosing opsonized zymosan particles (Butterick et al. 1983) . The H,O, formed from NADPH reacts with the cerium to form an electrondense reaction product, cerium perhydroxide, detected either visually or by X-ray microanalysis. volunteers receiving a-tocopherol were incubated with NADPH, no reaction product developed either within the phagocytic vesicles or on the plasma membrane, suggesting that a-tocopherol is capable of scavenging H202 needed for the formation of this reaction product.
Because we observed that a-tocopherol-replete cells destroy bacteria less efficiently than control cells, we turned our attention to another scavenger of H,02,
q -D H B , in an effort to manipulate better the autosxidative reactions engendered by activated PMN (Graziano et al. 1976). This drug has been identified as an orally-effective iron chelator (Graziano et al. 1974).
It is an aromatic compound having para-situated hydroxy groups which have the capability of reacting with free radicals to form longer-lived semiquinones. The semiquinones subsequently react with another free radical to form quinones. A scheme whereby 2,3-DHB might react is shown in Fig. 2 . We found that PMN phagocytosed at a faster rate and augmented their directed cell movement in the presence of 2,3-DHB in vitro ( 
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of 2,3-DHB, needed to alter PMN functions in vitro were readily attainable in vivo. The administration of 25 mg z,g-DHB/kg for use in Fe-chelation chemotherapy has resulted in a plasma concentration of 0.5-0.6 mM. In PMN 2,pDHB failed to inhibit the four-fold enhancement of cytosol enzymes responsible for hexose monophosphate shunt activity during phagocytosis (Boxer et al. 1978) . Analogues of 2,3-DHB, which in some instances scavenge hydroxyl radicals, were ineffective in enhancing PMN motile functions. Unlike a-tocopherol, the effect of 2,3-DHB, once removed from the extracellular media, was abrogated. a-Tocopherol is incorporated into the membrane lipid bilayer and can reduce intracellular levels of HIOz sufficiently to impair bacterial killing, whereas q -D H B failed to alter the bactericidal capacity of the PMN. Hence, 2,yDHB may be a more useful drug in some situations in enhancing PMN motile responses without compromising bactericidal potency.
Effect of a-tocopherol on PMN function in a patient with glutathione synthase (EC 6.3.2.3) deficiency A number of patients with glutathione synthase deficiency have been described in which reduced glutathione in the erythrocytes was markedly depressed and associated which chronic nonspemytic haemolytic anaemia and haemolytic crises following drug ingestion (Boivin & Galand, 1965; Meister, 1974) . The inheritance follows an autosomal recessive pattern. In the oxoprolinuric variant of glutathione synthase deficiency, nucleated cells such as leucocytes and fibroblasts have been found to have depressed glutathione levels (Spielberg et al. 1978) . PMN functions in one child suffering from neutropenia, following episodes of recurrent otitis media, revealed levels of glutathione synthase 5% of normal and levels of glutathione at 1~2 0 % of normal . While the chemotaxis of phatocytosis was normal, killing of ingested staphylococci was moderately impaired. H,O, production by phagocytosing PMN was increased while iodination and microtubule assembly were markedly impaired. All these defects were corrected after 3 months of oral a-tocopherol (20 mg (30 units)/kg per d) . Cellular levels of glutathione, however, did not rise. These findings suggest that the patient's PMN could not correctly detoxify H,O, which then led to microtubule dysfunction and impaired degranulation of lysosomes into phagosomes thus compromising iodination and bacterial killing. It would appear that a-tocopherol protected the glutathione synthase-deficient cells against oxidative damage.
Attenuation of lung damage in animals by antioxidants
The pathophysiological mechanisms underlying ARDS are an area of intense research interest. Indirect evidence exists regarding the ability of the PMN to produce acute lung injury by elaboration of toxic 0, metabolites (Till et al. 1982; Schraufstaller et al. 1984) . However, little has changed regarding pharmacological management of the disease. While compounds such as corticosteroids and inhibitors of arachidonic acid metabolism have shown promise in animal studies, confirmation of these findings in human diseases proves difficult and controversial (Brigham et ul. 1981; Perkowski et ul. 1983) . In an effort to discover alternative methods, we evaluated the ability of 2,3-DHB to prevent acute lung injury (Baldwin et al. 1986 ).
Various models have been utilized to study acute lung injury. Many have implicated PMNderived 0, metabolites as a cause of the damage (Till et ol. 1982 (Till et ol. , 1985 . One such model involves infusing cobra (Nuju nuju) venom factor (CVF) into the rat (Till et ul. 1982) . The lung injury in this manner appears to be mediated by PMN-generated 0, metabolites since both PMN depletion or previous administration of 0,-metabolite scavengers have a protective effect. Changes observed after treatment of the rat with CVF resemble those seen in adult ARDS; they include: (I) complement activation with formation of chemotactic fragments; (2) histological evidence of PMN accumulation in lung capillaries and alveolar spaces; (3) high permeability pulmonary oedema assessed by the leakage of radio-labelled albumin from the vascular space to the alveolar interstitium; (4) histological evidence of pulmonary oedema, alveolar haemorrhage and fibrin deposition. Using the CVF model, we tested the hypothesis that 2,3-DHB could protect the lung from such injury.
Using a permeability index that measures the amount of intravenously administered *251-labelled albumin that accumulates in lung tissue, we found that pretreatment with 2,yDHB reduced (K0.05) lung injury in CVF-treated rats in a dosedependent manner (Table 4) . Morphometric analysis of lung tissue indicated that the protection by 2,yDHB was not caused by inhibition of CVF-induced PMN sequestration within lung vasculature. Because Fe-saturated 2,3-DHB did not attenuate lung injury, and because in vitro experiments demonstrated that z,Q-DHB inhibited Fe-H,O,-induced peroxidation of phospholipid lyposomes, we suggested that z,yDHB may be protecting the lung via chelation of Fe as well as serving to protect the lung from H,O,-mediated damage.
Experimental thermal injury of rat skin (70'; 30 s) results also in activation of complement which leads to the appearance of Cg-related chemotactic activity in the serum, transient neutropenia and accumulation of PMN in pulmonary capillaries (Till et al. 1985) . These events ultimately lead to acute lung injury similar to that observed following the infusion of CVF into rats. Protection from acute lung injury following remote thermal injury (involving skin) can be achieved by depleting animals of complement or blood PMN or by systemic treatment of animals with combinations of catalase and SOD. The protective effects of catalase and SOD provide strong evidence that 0,derived free radicals released from complement-activated PMN are important mediators of lung injury secondary to skin bums. The nature of the 0, species appears to involve H20, and perhaps hydroxyl radical. In recent studies it was found that acute lung injury could be prevented by treatment of thermally-injured rats with the antioxidant a-tocopherol or with scavengers of hydroxyl radicals such as 2,3-DHB ( Fenton reaction in which hydroxyl radical is formed from H,O,.
Hydroxyl radical is highly reactive and can lead to generation of lipid peroxides. In the studies involving thermal injury, evidence was provided that the generation of lipid-peroxidation products which are detectable in burned skin, lung tissue and plasma may be dependent on hydroxyl release from complement-activated PMN. We found that both PMN depletion and pretreatment with hydroxyl-radical scavengers almost completely prevented the appearance of conjugated dimes in plasma of thermally injured animals. They also found that hydroxyl-radical scavengers and a-tocopherol decreased the plasma levels of conjugated dienes suggesting that lipid-peroxidation products are in some manner correlated with both the skin injury and lung injury. These findings provide some suggestions for treatments in clinical situations where there is reason to believe that 0,derived free radicals may be responsible for tissue injury. One such clinical situation is ARDS where increased amounts of oxidants are found in the breath of patients with the disorder (Baldwin et al. 1986 ).
Potential toxicity of large supplements of a-tocopherol Among the events accompanying phagocytosis by PMN are: (I) recognition of the target by cell-surface receptors; (2) triggering of the respiratory burst and granule release; (3) endocytic engulfment of the target (Curnutte & Boxer, 1985) . Recently the structural entities participating in Fc and C3b receptor-mediated recognition have been identified (Fearon, 1980; Mellman & Unkeless, 1980) . However, the physiological transduction mechanisms mediating the broad spectrum of functional changes are not known. Trans-membrane ion fluxes may constitute one early step in metabolic signalling during antibody phagocytosis (Young et al. 1983) . Arachidonic acid metabolism may be triggered by a phospholipase activity of the Fc receptors. Additionally, it has been suggested that a cell surface sulphydryl group participating in a sulphydryl-oxidation reaction may play a large role in IgG-dependent endocytic triggering (Petty, 1985) . We have hypothesized that release of oxidative factors by phagocytes may constitute a driving force in the IgG-mediated endocytosis of targets. T o test this hypothesis, we challenged PMN obtained from patients with chronic granulomatous disease (CGD) with immune complexes or Cg-coated opsonized paraffin-oil droplets. We found that the PMN obtained from the patients with CGD were unable to ingest immune complexes unless they were challenged with complexes capable of generating H202 (Petty et al. 1985) . In contrast, normal PMN were able to ingest immune complexes without difficulty. Similarly, the PMN from CGD patients were able to ingest Cs-coated, but not antibody-coated, paraffin-oil droplets. These observations indicate that defective antibodydependent endocytosis can be associated with PMN obtained from patients with CGD. As we previously indicated, the primary defect in CGD patients has been attributed to the absence of an NADPH oxidase. We suggest that a deficiency in antibody-dependent endocytosis is secondary to the defective respiratory burst of PMN. The PMN from the patients with CGD are then unable to form mixed disulphides between Fc receptor, a necessary prerequisite for Fc-receptor endocytosis. Based on the observation that PMN from CGD patients fail to internalize IgG immune complexes or IgGcoated particles, we next challenged normal PMN from subjects on 1.07 g (1600 units) a-tocopherol/d for I month. As indicated in Table   5 , their PMN showed markedly diminished ability to internalize the IgG-coated particles whereas their ability to internalize complement-coated particles was enhanced as previously noted. Additionally, normal PMN were found to have markedly impaired ability to ingest IgG-coated particles in the presence of catalase, a scavenger of H,02. These observations suggest that prolonged ingestion of high dose a-tocopherol potentially can lead to selective inhibition of PMN
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Nutrition and resistance to infection 343 phagocytosis. Clinically, one study of premature infants treated prophylactically with high doses of a-tocopherol for prevention of retinopathy revealed that the infants were at risk of developing sepsis and necrotizing enterocolitis (Johnson etal. 1985) . These particular clinical observations coupled with the in vitro observations relating potential toxicity to highdose a-tocopherol clearly indicate that the vitamin needs to be administered in moderation.
